GLENMARK PHARMACEUTICALS LTD

GLENMARK PHARMACEUTICALS LTD is primarily a Manufacturer.

Company Introduction:

GLENMARK PHARMACEUTICALS LTD is a leading global pharmaceutical company headquartered in India. The company is engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage formulations. Glenmark operates across multiple therapeutic areas such as dermatology, respiratory, oncology, and anti-infectives. With a strong focus on research and development, Glenmark has a significant global presence, with manufacturing facilities and R&D centers in several countries, serving markets in North America, Europe, Latin America, Asia, and Africa. Their business model encompasses both branded generics and innovative new chemical entities, establishing them as a prominent player in the global pharmaceutical industry.

Glenmark Pharmaceuticals Ltd. produces or sells a wide range of pharmaceutical products including:

1. Mometasone Furoate (dermatology)

2. Luliconazole (dermatology)

3. Tacrolimus (dermatology)

4. Fluticasone Propionate (respiratory)

5. Salmeterol (respiratory)

6. Formoterol Fumarate (respiratory)

7. Tiotropium Bromide (respiratory)

8. Sitagliptin (diabetes)

9. Metformin Hydrochloride (diabetes)

10. Telmisartan (cardiovascular)

11. Amlodipine (cardiovascular)

12. Amoxicillin Clavulanate (anti-infective)

13. Linezolid (anti-infective)

14. Azithromycin (anti-infective)

15. Diclofenac (pain management)

16. Ascoril (cough and cold)

17. Beclomethasone Dipropionate (dermatology, respiratory)

18. Clobetasol Propionate (dermatology)

19. Itraconazole (anti-fungal)

20. Budesonide (respiratory)